Literature DB >> 22105256

Trends in bilateral oophorectomy at the time of hysterectomy for benign disease.

Akiva P Novetsky1, Leslie R Boyd, John P Curtin.   

Abstract

OBJECTIVE: To identify patient characteristics associated with bilateral oophorectomy or removal of remaining ovary at the time of benign hysterectomy, and to estimate trends in the performance of oophorectomy from 2001 to 2006.
METHODS: This was a cross-sectional analysis using the New York State Department of Health Statewide Planning and Research Cooperative System. Women aged 18 years or older undergoing hysterectomies for benign gynecologic conditions were included. We evaluated factors associated with oophorectomy on both univariable and multivariable analyses and assessed for changes in performance of oophorectomy over the course of the study.
RESULTS: Forty-seven percent of 144,877 hysterectomies included oophorectomy. Women who underwent oophorectomy were older and were more likely to have a family history of breast or ovarian cancer, a personal history of breast cancer, ovarian cysts, or endometriosis. Women who underwent vaginal or laparoscopic hysterectomy or had uterine prolapse were less likely to undergo oophorectomy. Both race and insurance status were associated with performance of oophorectomy. From 2001 to 2006, there was an 8% absolute decrease in the performance of oophorectomy at the time of benign hysterectomy for women of all ages, with a 10.4% decrease in women aged younger than 55 (P for trend <.001).
CONCLUSION: Age, route of hysterectomy, and concomitant gynecologic diagnoses influence oophorectomy rate. From 2001 to 2006, a significant decrease in the performance of oophorectomy at the time of benign hysterectomy was noted in women aged younger than 55 years. Recent studies of complications of hormone therapy and prophylactic oophorectomy may have influenced patients' and physicians' decision-making, leading to lower oophorectomy rates. LEVEL OF EVIDENCE: II.

Entities:  

Mesh:

Year:  2011        PMID: 22105256     DOI: 10.1097/AOG.0b013e318236fe61

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  20 in total

Review 1.  Postmenopausal hormone therapy and cognition.

Authors:  Anna C McCarrey; Susan M Resnick
Journal:  Horm Behav       Date:  2015-04-30       Impact factor: 3.587

2.  Invited commentary: reproductive organ surgeries and breast cancer risk--apples, oranges, or fruit cocktail?

Authors:  David J Press; Leslie Bernstein
Journal:  Am J Epidemiol       Date:  2013-02-14       Impact factor: 4.897

3.  Personal, reproductive, and familial characteristics associated with bilateral oophorectomy in premenopausal women: A population-based case-control study.

Authors:  Walter A Rocca; Liliana Gazzuola Rocca; Carin Y Smith; Brandon R Grossardt; Stephanie S Faubion; Lynne T Shuster; Elizabeth A Stewart; Michelle M Mielke; Kejal Kantarci; Virginia M Miller
Journal:  Maturitas       Date:  2018-09-14       Impact factor: 4.342

4.  Cardiovascular and metabolic morbidity after hysterectomy with ovarian conservation: a cohort study.

Authors:  Shannon K Laughlin-Tommaso; Zaraq Khan; Amy L Weaver; Carin Y Smith; Walter A Rocca; Elizabeth A Stewart
Journal:  Menopause       Date:  2018-05       Impact factor: 2.953

5.  Sexual function in older women after oophorectomy.

Authors:  Elisabeth A Erekson; Deanna K Martin; Kejia Zhu; Maria M Ciarleglio; Divya A Patel; Marsha K Guess; Elena S Ratner
Journal:  Obstet Gynecol       Date:  2012-10       Impact factor: 7.661

6.  A Dose-Response Relationship Study of Prophylactic Nalbuphine to Reduce Pain During the Awakening Period in Patients Undergoing Laparoscopic Total Hysterectomy: A Randomized, Controlled, Double-Blind Clinical Study.

Authors:  Min Wang; Dongyue Wang; Jingzhi Zuo; Tianyu Liu; Zheng Niu; Juan Xie; Dunyi Qi
Journal:  Drug Des Devel Ther       Date:  2022-03-31       Impact factor: 4.162

7.  Indications and Route of Hysterectomy for Benign Diseases. Guideline of the DGGG, OEGGG and SGGG (S3 Level, AWMF Registry No. 015/070, April 2015)

Authors:  K J Neis; W Zubke; T Römer; K Schwerdtfeger; T Schollmeyer; S Rimbach; B Holthaus; E Solomayer; B Bojahr; F Neis; C Reisenauer; B Gabriel; H Dieterich; I B Runnenbaum; W Kleine; A Strauss; M Menton; I Mylonas; M David; L-C Horn; D Schmidt; P Gaß; A T Teichmann; P Brandner; W Stummvoll; A Kuhn; M Müller; M Fehr; K Tamussino
Journal:  Geburtshilfe Frauenheilkd       Date:  2016-04       Impact factor: 2.915

8.  Postoophorectomy estrogen use and breast cancer risk.

Authors:  Hazel B Nichols; Amy Trentham-Dietz; Polly A Newcomb; Linda J Titus; Kathleen M Egan; John M Hampton; Kala Visvanathan
Journal:  Obstet Gynecol       Date:  2012-07       Impact factor: 7.661

9.  A sustained decline in postmenopausal hormone use: results from the National Health and Nutrition Examination Survey, 1999-2010.

Authors:  Brian L Sprague; Amy Trentham-Dietz; Kathleen A Cronin
Journal:  Obstet Gynecol       Date:  2012-09       Impact factor: 7.661

10.  Incidence, time trends, laterality, indications, and pathological findings of unilateral oophorectomy before menopause.

Authors:  Shannon K Laughlin-Tommaso; Elizabeth A Stewart; Brandon R Grossardt; Liliana Gazzuola Rocca; Walter A Rocca
Journal:  Menopause       Date:  2014-05       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.